VideoHIVHealth Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025Abstract #1 Transforming HIV Education through Illustrated Storytelling: Lessons from Singapore’s National Centre for Infectious Diseases World Aids Day Campaign – Arun KumarView Video
DRDanvic RosadiñoDIHVideoHIVHealth Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025Upscaling Community Reach Through EMBRACE-ing Virtual Clinic Model - Danvic RosadiñoView Video
MAJMMario Alberto Jose MartinsB.Eng, M.MVideoHIVHealth Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025Courage and Connectivity in Indonesia: Community and Digital Responses to HIV Stigma - Mario Alberto Jose MartinsView Video
BABruce AginsMD, MPHVideoHIVHealth Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025Quality Improvement as Tool to Reduce Stigma & Discrimination - Bruce AginsView Video
DTTDoan Thanh TungBAVideoHealth Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025TAP4S Initiative: From Click to Clinic – A Flexible HIV/STI Care Continuum Model by Lighthouse Vietnam - Doan Thanh TungView Video
Video23rd European Meeting on HIV & Hepatitis 2025Quick Recap: 23rd European Meeting on HIV & Hepatitis 2025View Video
Video1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Long-Acting Injectable Formulation of Ivermectin as a New Vector Control Tool to Reduce Malaria Transmission - Quiterie Savary de BeauregardView Video
VideoViral Hepatitis and Liver Disease1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract LB #4 Global Perspectives of People Living with Hepatitis B on Long-Acting Antivirals: Survey Results - Yasmin IbrahimView Video
VideoHIVTuberculosisViral Hepatitis and Liver Disease1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract #9 LAPaL: Your Free Digital Compass in the Evolving Long-Acting Therapeutics Landscape - Lobna GaayebView Video
VideoHIV1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract #8 VH3810109 (N6LS) Efficacy and Safety in Adults Who Are Virologically Suppressed: The EMBRACE Study - Rulan GrieselView Video
VideoTuberculosis1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract LB #3 Clinical Development of Long-Acting Formulations for TB Treatment and Prevention: Insights from the Bedaquiline Long-Acting TMC207TBC1006 Phase 1 Trial – Vivan CoxView Video
VideoTuberculosis1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract #7 First in Human Dose Predictions Scaled from Preclinical Pharmacokinetics for LAI Rifabutin - Doaa Ahmed MohamedView Video
